Aug 9 (Reuters) – Drugmaker Gilead Sciences (GILD.O) plans to announce on Tuesday that it will provide up to $5 million in grants to help a coalition of LGBTQ+ and human rights advocacy groups craft public health responses to monkeypox outbreaks, the company said. Outside of Africa, where the virus is endemic, new cases have largely occurred among gay and bisexual men. Experts warn that the virus could spread to other populations, especially due to vaccine shortages. The World Health Organization and the United States have declared monkeypox a public health emergency.